Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Debridement of the Sinus Cavity Following Primary Functional Endoscopic Sinus Surgery (FESS): A Randomized Controlled Trial.

NCT04093193 is registered in ClinicalTrials.gov with St. Paul's Hospital, Canada as lead sponsor.

NCT NCT04093193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04093193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Debridement of the Sinus Cavity Following Primary Functional Endoscopic Sinus Surgery (FESS): A Randomized Controlled Trial.
Lead sponsor
St. Paul's Hospital, Canada
Phase
Not applicable
Overall status
Unknown status
Start date
June 22, 2018
Completion date
September 1, 2021
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis (diagnosis)